Temporary Use of the Jarvik-7 Artificial Heart — The Pittsburgh Experience
Nearly concurrently with the development of the pneumatic artificial heart [1, 2], cardiac transplantation emerged from an experimental to a therapeutic procedure . By 1987, the International Cardiac Transplant Registry had 4600 entries, and current 1-year expectation for survival exceeds 80% . The increased use of cardiac transplantation has prolonged the waiting period even for those patients who are most critically ill - from less than 5 days in 1980, when cardiac transplantation was performed in five centers in the United States, to more than 42 days in 1986, when the procedure was performed in more than 60 centers . Our group has previously shown that there is a group of mortally ill patients who might survive if their circulation could be temporarily and safely supported by an intravenous, inotropic system and the intra-aortic balloon pump (IABP) .
KeywordsCreatinine Pneumonia Heparin Pseudomonas Bilirubin
Unable to display preview. Download preview PDF.
- 1.Working Group on Mechanical Circulatory Support of the National Heart, Lung, and Blood Institute (1985) Artificial heart and assist devices: directions, needs, costs, societal, and ethical issues. National Heart, Lung, and Blood Institute, Bethesda, May 1985Google Scholar
- 4.Kaye MP (1987) The registry of the International Society for Heart Transplantation: fourth official report - 1987. Heart Transplant 6:63–67Google Scholar
- 12.Cabrol CE, Gandjbakhch I, Pavie A et al. (1988) Orthotopic heart transplantation survival after total artificial heart implantation. Presented at the annual meeting, Am Assn Thorac Surg, Los AngelesGoogle Scholar